Therefore, reactivating the Hippo signaling pathway to inhibit YAP/TAZ transcriptional activation with two independent chemical inhibitors (dasatinib, an SRC inhibitor [42] or Y27632, a ROCK inhibitor [43]) markedly suppressed AXL expression in A549 and TD cells (Fig. 3E). The gene discussed is SRC; the disease is thanatophoric dysplasia.